发明名称 |
Hepatitis C virus inhibitors |
摘要 |
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit RNA-containing virus, particularly the hepatitis C virus (HCV). Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. |
申请公布号 |
US8697704(B2) |
申请公布日期 |
2014.04.15 |
申请号 |
US201113207910 |
申请日期 |
2011.08.11 |
申请人 |
QIU YAO-LING;PENG XIAOWEN;WANG CE;OR YAT SUN;ENANTA PHARMACEUTICALS, INC. |
发明人 |
QIU YAO-LING;PENG XIAOWEN;WANG CE;OR YAT SUN |
分类号 |
C07D417/14;C07D413/14;C07D498/08 |
主分类号 |
C07D417/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|